You searched for "patients"
Cataract incidence rates in patients from the UK suffering with diabetes mellitus
1 October 2018
| Rupert Bourne (Prof), Clare Bailey
|
EYE - Cataract, EYE - Refractive, EYE - General
The authors summarise the main findings from a recent study which investigated the incidence rates of cataract in patients with or without diabetes mellitus (DM). Background to the study Worldwide, the World Health Organization (WHO) estimates that 253 million people...
A retrospective medical notes review in patients with poor vision due to NAION
1 December 2021
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Non-arteritic anterior ischaemic optic neuropathy, NAION, severe visual loss, visual acuity
Very severe visual loss (hand movements or less) is typical of arteritic anterior ischaemic optic neuropathy (AION) and relatively rare in non-arteritic AION (NAION). This study aimed to report the frequency of very poor visual acuity (VA) in NAION. The...
Differences in elastometry of cornea and optic nerve head in both eyes of patients with NAION
1 February 2019
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Corneal hysteresis, corneal resistance factor, non-arteritic anterior ischaemic neuropathy, optic nerve head biomechanics, real-time elastography
Non-arteritic anterior ischaemic optic neuropathy (NAION) is an important cause of visual loss in the middle aged and elderly population. This prospective cross-sectional study investigates the biomechanical properties of optic nerve head (ONH) and cornea in both eyes of patients...
Intravitreal bevacizumab vs. triamcinolone in patients with DMO at the time of cataract surgery
1 October 2016
| Anjali Gupta
|
EYE - Vitreo-Retinal
This prospective, single masked randomised control trial (RCT) compared visual and anatomical outcomes when either intravitreal bevacizumab (BVB) or triamcinolone (TA) was administered at the time of cataract surgery and at subsequent review, if required, in patients with diabetic macula...
Injection frequency and anatomic outcomes following conversion to Aflibercept in neovascular AMD patients
1 December 2014
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a retrospective study of patients with neovascular age-related macular degeneration (AMD) treated with intravitreal Lucentis and / or Avastin who were switched to aflibercept (Eylea). This study was carried out by the Casey Eye Institute retinal clinics, between...
Lens surgery in patients with lens subluxation misdiagnosed as primary angle-closure glaucoma
1 August 2019
| Kurt Spiteri Cornish
|
EYE - Glaucoma
|
Angle-closure glaucoma, intraocular pressure control, lens subluxation, lens surgery, misdiagnosis
Lens subluxation can be caused by many conditions including Marfan syndrome and other hereditary conditions, and blunt trauma. Lens displacement can cause pupillary block and angle closure. This is commonly misdiagnosed as primary angle closure glaucoma (PACG), which can lead...
OCT prognostic factors in AMD patients with peripapillary choroidal neovascularisation
3 August 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this retrospective study the authors aimed to investigate the correlation between optical coherence tomography (OCT) findings and visual acuity outcomes after treatment with intravitreal bevacizumab (IVB) injections for age-related macular degeneration (AMD) patients with peripapillary choroidal neovascularisation (PPCNV). Data...
Prognostic factors for visual acuity in patients with LHON after gene therapy
5 February 2020
| Ivan Yip
|
EYE - Vitreo-Retinal
This retrospective study investigates prognostic factors affecting the visual acuity after a single intravitreal injection of rAAV2-ND4 gene therapy in 53 patients with Leber’s hereditary optic neuropathy (LHON) with mutation at site 11 778. Patients were reviewed one and three...
Are any precautions needed when performing cataract surgery in thrombocytopenic patients?
In this retrospective multi-centre study, charts for 196 eyes of 150 thrombocytopenic patients were reviewed. The mean preoperative platelet level was 73.0 ± 20.5 × 103/μL (median of 76.0 × 103/μL), with a range of 17 to 100 × 103/μL...Comparison of false-negative responses in glaucoma patients and normal observers
1 October 2014
| Lorraine North
|
EYE - Glaucoma
The authors compared false negative rates for full threshold (FULL) and Swedish Interactive Threshold Algorithm (SITA) standard automated perimetry in healthy control subjects and glaucoma patients. Twenty-four subjects underwent visual field testing of one eye five times within six weeks...
Intravitreal Bevacizumab for the prevention of postoperative proliferative vitreoretinopathy in high-risk patients
3 April 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This single- centre observational retrospective study was conducted to evaluate the effect of intravitreal injection of bevacizumab at the time surgery for rhegmatogenous retinal detachment (RRD) repair on postoperative proliferative vitreoretinopathy (PVR) in patients at high risk selected by laser...
What are the characteristics of patients reporting diplopia in giant cell arteritis?
4 December 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective study of individuals diagnosed with giant cell arteritis (GCA) consecutively over a six-year period at a single tertiary ophthalmic centre. The characteristics of binocular diplopia prior to GCA diagnosis was collected from medical records and...